245 related articles for article (PubMed ID: 8460218)
21. Fast 3D Near-infrared breast imaging using indocyanine green for detection and characterization of breast lesions.
Schneider P; Piper S; Schmitz CH; Schreiter NF; Volkwein N; Lüdemann L; Malzahn U; Poellinger A
Rofo; 2011 Oct; 183(10):956-63. PubMed ID: 21972043
[TBL] [Abstract][Full Text] [Related]
22. Benign and malignant breast disease: magnetic resonance and radiofrequency pulse sequences.
el Yousef SJ; O'Connell DM; Duchesneau RH; Smith MJ; Hubay CA; Guyton SP
AJR Am J Roentgenol; 1985 Jul; 145(1):1-8. PubMed ID: 2988320
[TBL] [Abstract][Full Text] [Related]
23. How to optimize clinical breast MR imaging practices and techniques on Your 1.5-T system.
Rausch DR; Hendrick RE
Radiographics; 2006; 26(5):1469-84. PubMed ID: 16973776
[TBL] [Abstract][Full Text] [Related]
24. Silicone-suppressed 3D MRI of the breast using rotating delivery of off-resonance excitation.
Harms SE; Jensen RA; Meiches MD; Flamig DP; Evans WP
J Comput Assist Tomogr; 1995; 19(3):394-9. PubMed ID: 7790549
[TBL] [Abstract][Full Text] [Related]
25. Breast disease: tissue characterization with Gd-DTPA enhancement profiles.
Stack JP; Redmond OM; Codd MB; Dervan PA; Ennis JT
Radiology; 1990 Feb; 174(2):491-4. PubMed ID: 2296657
[TBL] [Abstract][Full Text] [Related]
26. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
[TBL] [Abstract][Full Text] [Related]
27. Detection of breast malignancy: diagnostic MR protocol for improved specificity.
Huang W; Fisher PR; Dulaimy K; Tudorica LA; O'Hea B; Button TM
Radiology; 2004 Aug; 232(2):585-91. PubMed ID: 15205478
[TBL] [Abstract][Full Text] [Related]
28. Malignant spiculated breast masses: dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation.
Gokalp G; Topal U; Yildirim N; Tolunay S
Eur J Radiol; 2012 Feb; 81(2):203-8. PubMed ID: 21236612
[TBL] [Abstract][Full Text] [Related]
29. A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions: initial results.
Pinker K; Grabner G; Bogner W; Gruber S; Szomolanyi P; Trattnig S; Heinz-Peer G; Weber M; Fitzal F; Pluschnig U; Rudas M; Helbich T
Invest Radiol; 2009 Sep; 44(9):553-8. PubMed ID: 19652611
[TBL] [Abstract][Full Text] [Related]
30. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
Gökalp G; Topal U
Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
[TBL] [Abstract][Full Text] [Related]
31. Fat suppression with spectrally selective inversion vs. high spectral and spatial resolution MRI of breast lesions: qualitative and quantitative comparisons.
Fan X; Abe H; Medved M; Foxley S; Arkani S; Zamora MA; Olopade OI; Newstead GM; Karczmar GS
J Magn Reson Imaging; 2006 Dec; 24(6):1311-5. PubMed ID: 17096393
[TBL] [Abstract][Full Text] [Related]
32. [The radial scar in contrast media-enhanced MR mammography].
Baum F; Fischer U; Füzesi L; Obenauer S; Vosshenrich R; Grabbe E
Rofo; 2000 Oct; 172(10):817-23. PubMed ID: 11111293
[TBL] [Abstract][Full Text] [Related]
33. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
[TBL] [Abstract][Full Text] [Related]
34. MR imaging of mammographically detected clustered microcalcifications: is there any value?
Westerhof JP; Fischer U; Moritz JD; Oestmann JW
Radiology; 1998 Jun; 207(3):675-81. PubMed ID: 9609890
[TBL] [Abstract][Full Text] [Related]
35. Galactography: mammary duct contrast examination.
Diner WC
AJR Am J Roentgenol; 1981 Oct; 137(4):853-6. PubMed ID: 6974984
[No Abstract] [Full Text] [Related]
36. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation.
Orel SG; Schnall MD; LiVolsi VA; Troupin RH
Radiology; 1994 Feb; 190(2):485-93. PubMed ID: 8284404
[TBL] [Abstract][Full Text] [Related]
37. MR imaging of the breast after surgery for breast cancer.
Whitehouse GH; Moore NR
Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):591-603. PubMed ID: 7489311
[TBL] [Abstract][Full Text] [Related]
38. [Diagnosis of non-palpable lesions of the breast. Preliminary results].
Amato C; Cipolla C; Latteri M; Di Lisi G; Salanitro L; Taormina FM; Cassano T; Grassi N
Minerva Chir; 1988 Feb; 43(4):311-5. PubMed ID: 2835710
[No Abstract] [Full Text] [Related]
39. [Diagnosis of intraductal spread of breast cancer by high-resolution MR imaging: correlation between MR imaging and pathohistological findings].
Date S
Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Apr; 58(5):212-20. PubMed ID: 9617156
[TBL] [Abstract][Full Text] [Related]
40. Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound.
Vassiou K; Kanavou T; Vlychou M; Poultsidi A; Athanasiou E; Arvanitis DL; Fezoulidis IV
Eur J Radiol; 2009 Apr; 70(1):69-76. PubMed ID: 18295425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
